Insmed Inc (NAS:INSM)
$ 25.495 -0.475 (-1.83%) Market Cap: 3.79 Bil Enterprise Value: 4.28 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 77/100

Insmed Inc at Barclays Global Healthcare Conference Transcript

Mar 15, 2023 / 08:05PM GMT
Release Date Price: $17.87 (-2.46%)
Leiyang Wang
Barclays Bank PLC, Research Division - Research Analyst

Hi, everyone. Thanks for joining us. My name is Leiyang Wang, and I'm covering SMID Cap file over here at Barclays. I'm pleased to be joined by Sara Bonstein, the Chief Financial Officer of Insmed. Sara, thank you for joining us.

Sara M. Bonstein
Insmed Incorporated - CFO

Yes, thanks us for having us. Really appreciate it.

Leiyang Wang
Barclays Bank PLC, Research Division - Research Analyst

Definitely. So you want to do a little intro with -- about Insmed and then we can get into questions?

Sara M. Bonstein
Insmed Incorporated - CFO

Sure. So I'll be happy to give you an overview of -- a high-level overview of the company. As you know, our focus is a serious and rare diseases. And what I -- as we think about our North Star, the patient, it's really about how do we develop either best-in-class, first-in-class, best-in-disease, first-in-disease drugs with the impact to our patients hope have best

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot